Stem cell therapy for recent brain bleed
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether stem cells can help people recover from a recent, moderate-sized brain bleed (intracerebral hemorrhage). The stem cells are given to reduce damage and improve healing during the first days after the bleed. It may be an option if you had a stroke from a bleed 3 to 10 days ago and you otherwise are in stable health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You had a bleed in the brain (not from injury or other causes) and it's been 3 to 10 days since it started.
- The size of the bleed is between 15 and 30 mL (roughly the size of a small egg).
- You do not have serious medical conditions like cancer, autoimmune disease, recent stroke with disability, or unstable vital signs.
- You are not pregnant or breastfeeding, and you have not had surgery or plan to have surgery to remove the clot.
- Your blood tests show good liver, kidney, and blood cell function, and you are not taking blood thinners making your INR too high.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug called cerebrolysin can help people who have a bleeding stroke in the outer part of the brain (lobar hemorrhage). It looks at safety and how well it works.
This trial tests a non-invasive ultrasound device to help clear blood clots from the brain after a spontaneous bleed. It may be an option for people with small to medium-sized bleeds who do not need surgery.
This trial tests whether a patient's own bone marrow stem cells can help improve recovery after a moderate-to-severe ischemic stroke that happened 3 to 12 months ago.
This study tests whether a treatment made from donor stem cells (called mesenchymal stromal cells) can help people recover from a severe traumatic brain injury. The cells are given through a vein within 48 hours of the injury.
This trial is testing a new treatment using stem cells from donated umbilical cord tissue to help people recover from a recent moderate to severe stroke. It is for patients who cannot receive standard clot-busting treatments.
This trial tests whether a patient's own stem cells can be safely injected into the brain to help recovery after a stroke. It is for people who had an ischemic stroke 6 months to 5 years ago and still have moderate to severe symptoms.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.